These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36430389)

  • 1. Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy.
    Landim-Vieira M; Kahmini AR; Engel M; Cannon EN; Amat-Alarcon N; Judge DP; Pinto JR; Chelko SP
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Fat Diet Augments Myocardial Inflammation and Cardiac Dysfunction in Arrhythmogenic Cardiomyopathy.
    Centner AM; Shiel EA; Farra W; Cannon EN; Landim-Vieira M; Salazar G; Chelko SP
    Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PPARα Ameliorates Cardiac Fibrosis in Dsg2-Deficient Arrhythmogenic Cardiomyopathy.
    Qiu Z; Zhao Y; Tao T; Guo W; Liu R; Huang J; Xu G
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.
    Chelko SP; Keceli G; Carpi A; Doti N; Agrimi J; Asimaki A; Beti CB; Miyamoto M; Amat-Codina N; Bedja D; Wei AC; Murray B; Tichnell C; Kwon C; Calkins H; James CA; O'Rourke B; Halushka MK; Melloni E; Saffitz JE; Judge DP; Ruvo M; Kitsis RN; Andersen P; Di Lisa F; Paolocci N
    Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Innate Immune Injury in Arrhythmogenic Cardiomyopathy.
    Chelko SP; Penna V; Engel M; Landim-Vieira M; Cannon EN; Lavine K; Saffitz JE
    bioRxiv; 2023 Jul; ():. PubMed ID: 37503283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac sympathetic neurons are additional cells affected in genetically determined arrhythmogenic cardiomyopathy.
    Vanaja IP; Scalco A; Ronfini M; Bona AD; Olianti C; Rizzo S; Chelko SP; Corrado D; Sacconi L; Basso C; Mongillo M; Zaglia T
    J Physiol; 2024 Aug; ():. PubMed ID: 39141822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy.
    Panigrahy D; Kelly AG; Wang W; Yang J; Hwang SH; Gillespie M; Howard I; Bueno-Beti C; Asimaki A; Penna V; Lavine K; Edin ML; Zeldin DC; Hammock BD; Saffitz JE
    bioRxiv; 2024 Feb; ():. PubMed ID: 38463975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telmisartan is the most effective ARB to increase adiponectin via PPARα in adipocytes.
    Hattori N; Yamada A; Nakatsuji S; Matsuda T; Nishiyama N; Shimatsu A
    J Mol Endocrinol; 2022 May; 69(1):259-268. PubMed ID: 35354667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
    Chelko SP; Asimaki A; Lowenthal J; Bueno-Beti C; Bedja D; Scalco A; Amat-Alarcon N; Andersen P; Judge DP; Tung L; Saffitz JE
    Circulation; 2019 Oct; 140(18):1491-1505. PubMed ID: 31533459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective Desmosomal Adhesion Causes Arrhythmogenic Cardiomyopathy by Involving an Integrin-αVβ6/TGF-β Signaling Cascade.
    Schinner C; Xu L; Franz H; Zimmermann A; Wanuske MT; Rathod M; Hanns P; Geier F; Pelczar P; Liang Y; Lorenz V; Stüdle C; Maly PI; Kauferstein S; Beckmann BM; Sheikh F; Kuster GM; Spindler V
    Circulation; 2022 Nov; 146(21):1610-1626. PubMed ID: 36268721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular insight into arrhythmogenic cardiomyopathy caused by DSG2 mutations.
    Zhang B; Wu Y; Yang X; Xiang Y; Yang B
    Biomed Pharmacother; 2023 Nov; 167():115448. PubMed ID: 37696084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central role for GSK3β in the pathogenesis of arrhythmogenic cardiomyopathy.
    Chelko SP; Asimaki A; Andersen P; Bedja D; Amat-Alarcon N; DeMazumder D; Jasti R; MacRae CA; Leber R; Kleber AG; Saffitz JE; Judge DP
    JCI Insight; 2016 Apr; 1(5):. PubMed ID: 27170944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of PPAR
    Lin Y; Liu R; Huang Y; Yang Z; Xian J; Huang J; Qiu Z; Lin X; Zhang M; Chen H; Wang H; Huang J; Xu G
    Acta Pharm Sin B; 2023 Jan; 13(1):192-203. PubMed ID: 36815030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy.
    Yang Z; Li T; Xian J; Chen J; Huang Y; Zhang Q; Lin X; Lu H; Lin Y
    FASEB J; 2022 Jul; 36(7):e22410. PubMed ID: 35713937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting arrhythmogenic macrophages: lessons learned from arrhythmogenic cardiomyopathy.
    Mesquita T; Cingolani E
    J Clin Invest; 2024 May; 134(10):. PubMed ID: 38747296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left-dominant arrhythmogenic cardiomyopathy: an association with desmoglein-2 gene mutation-a case report.
    Lao N; Laiq Z; Courson J; Al-Quthami A
    Eur Heart J Case Rep; 2021 Jun; 5(6):ytab213. PubMed ID: 34263121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NFĸB signaling drives myocardial injury via CCR2+ macrophages in a preclinical model of arrhythmogenic cardiomyopathy.
    Chelko SP; Penna VR; Engel M; Shiel EA; Centner AM; Farra W; Cannon EN; Landim-Vieira M; Schaible N; Lavine K; Saffitz JE
    J Clin Invest; 2024 Apr; 134(10):. PubMed ID: 38564300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation.
    Younis F; Stern N; Limor R; Oron Y; Zangen S; Rosenthal T
    Metabolism; 2010 Aug; 59(8):1200-9. PubMed ID: 20070992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological suppression of the WNT signaling pathway attenuates age-dependent expression of the phenotype in a mouse model of arrhythmogenic cardiomyopathy.
    Cheedipudi SM; Fan S; Rouhi L; Marian AJ
    J Cardiovasc Aging; 2021; 1(3):. PubMed ID: 34447973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-γ by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions.
    Nenicu A; Körbel C; Gu Y; Menger MD; Laschke MW
    Hum Reprod; 2014 May; 29(5):1011-24. PubMed ID: 24578472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.